Urokinase receptor is a key player in tumour progression.
作者信息
Taniguchi T, Lemoine N R, Kakkar A K
机构信息
Imperial Cancer Research Fund Molecular Oncology Unit, Imperial College School of Medicine, Hammersmith Campus, Du Cane Road, London W12 0NN, UK.
出版信息
Gut. 1998 Dec;43(6):739-40. doi: 10.1136/gut.43.6.739.
Abstract
摘要
相似文献
1
Urokinase receptor is a key player in tumour progression.尿激酶受体是肿瘤进展中的关键因素。
Gut. 1998 Dec;43(6):739-40. doi: 10.1136/gut.43.6.739.
2
Plasminogen activators and inhibitor type-1 in alveolar osteitis.牙槽骨炎中的纤溶酶原激活剂和1型抑制剂
Eur J Oral Sci. 2006 Dec;114(6):500-3. doi: 10.1111/j.1600-0722.2006.00412.x.
3
[The structure and function of urokinase receptor and its expression in neoplastic tissues].
Zhonghua Yi Xue Za Zhi. 1995 May;75(5):315-7.
4
Plasminogen activation on tumor cell surface and its involvement in human leukemia.
Adv Cancer Res. 1996;69:101-33. doi: 10.1016/s0065-230x(08)60861-1.
5
6
Plasminogen activator-dependent pericellular proteolysis.纤溶酶原激活剂依赖性细胞周缘蛋白水解作用。
Br J Haematol. 1991 Dec;79(4):537-43. doi: 10.1111/j.1365-2141.1991.tb08078.x.
7
The urokinase system of plasminogen activator plays a role in amyotrophic lateral sclerosis (ALS) pathogenesis.纤溶酶原激活物的尿激酶系统在肌萎缩侧索硬化症（ALS）发病机制中起作用。
Exp Neurol. 2008 Jun;211(2):332-3. doi: 10.1016/j.expneurol.2008.02.029. Epub 2008 Mar 14.
8
Plasminogen activators and their inhibitors: regulators of extracellular proteolysis and cell function.纤溶酶原激活剂及其抑制剂：细胞外蛋白水解和细胞功能的调节因子。
Comp Biochem Physiol B. 1988;90(4):691-708. doi: 10.1016/0305-0491(88)90323-9.
9
Urokinase plasminogen activator system: a multifunctional role in tumor progression and metastasis.尿激酶型纤溶酶原激活物系统：在肿瘤进展和转移中的多功能作用
Clin Orthop Relat Res. 2003 Oct(415 Suppl):S46-58. doi: 10.1097/01.blo.0000093845.72468.bd.
10
Growth factor-dependent proliferation and invasion of muscle satellite cells require the cell-associated fibrinolytic system.肌肉卫星细胞的生长因子依赖性增殖和侵袭需要细胞相关的纤维蛋白溶解系统。
Biol Chem. 2002 Jan;383(1):127-36. doi: 10.1515/BC.2002.013.
Zotero 插件